{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:31:23Z","timestamp":1779121883044,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bemcentinib is a newly developed AXL inhibitor that is currently under investigation in phase II trails for the treatment of acute myeloblastic leukemia (AML). Clinical and radiographic findings in this case were very similar to cases of MRONJ in patients receiving Sunitinib or other anti-angiogenetic substances, assuming that Bemcentinib may cause similar oral side effects. We present a male 81-year-old patient with a manifestation of alveolar bone necrosis at the central upper incisors following a 2-month regimen with the AXL-inhibitor Bemcentinib, administered for the treatment of secondary acute myeloblastic leukemia (sAML). Due to the duration of less than 8 weeks, the osteonecrosis was diagnosed as necrotizing periodontitis, but the intraoral clinical and radiographic findings were also compatible with the differential diagnosis of medication-related osteonecrosis of the jaw (MRONJ, stage II). Following to discontinuation of Bemcentinib, the affected bone was surgically revised including the removal of a demarcated bone sequester under preventive antibiotic treatment (metronidazole 400 mg t.i.d.). We hypothesize that Bemcentinib might increase the susceptibility for osteonecrosis of the jaw, probably related to its antiangiogenic effects and the resulting modulation of host immune response. Based on the current observations, it can be assumed that oro-dental health might be significant also prior and during treatment with Bemcentinib for the prevention of MRONJ.<\/jats:p>","DOI":"10.1007\/s10006-020-00851-w","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:02:21Z","timestamp":1590094941000},"page":"353-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Necrotizing periodontitis or medication-related osteonecrosis of the jaw (MRONJ) in a patient receiving Bemcentinib\u2014a case report"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0681-1528","authenticated-orcid":false,"given":"Caspar V.","family":"Bumm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Folwaczny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta C.","family":"W\u00f6lfle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"issue":"7","key":"851_CR1","first-page":"952","volume":"16","author":"A Agrillo","year":"2012","unstructured":"Agrillo A, Nastro Siniscalchi E, Facchini A, Filiaci F, Ungari C (2012) Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports. Eur Rev Med Pharmacol Sci 16(7):952\u2013957","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"851_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tripleo.2011.08.024","volume":"113","author":"O Nicolatou-Galitis","year":"2012","unstructured":"Nicolatou-Galitis O, Migkou M, Psyrri A, Bamias A, Pectasides D, Economopoulos T, Raber-Durlacher JE, Dimitriadis G, Dimopoulos MA (2012) Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol 113(2):234\u2013238","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"851_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","volume":"113","author":"Y Fleissig","year":"2012","unstructured":"Fleissig Y, Regev E, Lehman H (2012) Sunitinib related osteonecrosis of jaw: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 113(3):e1\u2013e3","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"851_CR4","unstructured":"Medication-related osteonecrosis of the Jaw 2014 Update [https:\/\/www.aaoms.org\/docs\/govt_affairs\/advocacy_white_papers\/mronj_position_paper.pdf]"},{"issue":"30","key":"851_CR5","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.18632\/oncotarget.26882","volume":"10","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Siemann DW (2019) Axl signaling is an important mediator of tumor angiogenesis. Oncotarget 10(30):2887\u20132898","journal-title":"Oncotarget"},{"issue":"28","key":"851_CR6","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.2174\/0929867324666170511113811","volume":"24","author":"L Antonuzzo","year":"2017","unstructured":"Antonuzzo L, Lunghi A, Petreni P, Brugia M, Laffi A, Giommoni E, Mela MM, Mazzoni F, Balestri V, Costanzo FD (2017) Osteonecrosis of the jaw and angiogenesis inhibitors: a revival of a rare but serous side effect. Curr Med Chem 24(28):3068\u20133076","journal-title":"Curr Med Chem"},{"issue":"2","key":"851_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00520-018-4501-x","volume":"27","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K et al (2019) Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Supportive Care in cancer : official Journal of the Multinational Association of Supportive Care in Cancer 27(2):383\u2013394","journal-title":"Supportive Care in cancer : official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"14","key":"851_CR8","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1182\/blood-2013-03-491431","volume":"122","author":"I Ben-Batalla","year":"2013","unstructured":"Ben-Batalla I, Schultze A, Wroblewski M, Erdmann R, Heuser M, Waizenegger JS, Riecken K, Binder M, Schewe D, Sawall S et al (2013) Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. Blood 122(14):2443\u20132452","journal-title":"Blood"},{"issue":"2","key":"851_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/17474086.2015.997704","volume":"8","author":"M Janning","year":"2015","unstructured":"Janning M, Ben-Batalla I, Loges S (2015) Axl inhibition: a potential road to a novel acute myeloid leukemia therapy? Expert Rev Hematol 8(2):135\u2013138","journal-title":"Expert Rev Hematol"},{"issue":"10","key":"851_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ni.2986","volume":"15","author":"A Zagorska","year":"2014","unstructured":"Zagorska A, Traves PG, Lew ED, Dransfield I, Lemke G (2014) Diversification of TAM receptor tyrosine kinase function. Nat Immunol 15(10):920\u2013928","journal-title":"Nat Immunol"},{"issue":"1","key":"851_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","volume":"18","author":"KV Myers","year":"2019","unstructured":"Myers KV, Amend SR, Pienta KJ (2019) Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer 18(1):94","journal-title":"Mol Cancer"},{"issue":"6","key":"851_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131(6):1124\u20131136","journal-title":"Cell"},{"issue":"14","key":"851_CR13","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-17-0392","volume":"77","author":"J Antony","year":"2017","unstructured":"Antony J, Huang RY (2017) AXL-driven EMT state as a targetable conduit in cancer. Cancer Res 77(14):3725\u20133732","journal-title":"Cancer Res"},{"issue":"1","key":"851_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-019-1090-3","volume":"18","author":"C Zhu","year":"2019","unstructured":"Zhu C, Wei Y, Wei X (2019) AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Mol Cancer 18(1):153","journal-title":"Mol Cancer"},{"issue":"4","key":"851_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/bjc.2016.428","volume":"116","author":"CM Gay","year":"2017","unstructured":"Gay CM, Balaji K, Byers LA (2017) Giving AXL the axe: targeting AXL in human malignancy. Br J Cancer 116(4):415\u2013423","journal-title":"Br J Cancer"},{"issue":"1","key":"851_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imr.12522","volume":"276","author":"YT Akalu","year":"2017","unstructured":"Akalu YT, Rothlin CV, Ghosh S (2017) TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy. Immunol Rev 276(1):165\u2013177","journal-title":"Immunol Rev"},{"issue":"5","key":"851_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1189\/jlb.0909610","volume":"87","author":"F Alciato","year":"2010","unstructured":"Alciato F, Sainaghi PP, Sola D, Castello L, Avanzi GC (2010) TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes\/macrophages. J Leukoc Biol 87(5):869\u2013875","journal-title":"J Leukoc Biol"},{"issue":"7","key":"851_CR18","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.4049\/jimmunol.1401258","volume":"193","author":"T Shibata","year":"2014","unstructured":"Shibata T, Habiel DM, Coelho AL, Hogaboam CM (2014) Axl receptor blockade protects from invasive pulmonary aspergillosis in mice. Journal of immunology (Baltimore, Md : 1950) 193(7):3559\u20133565","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"issue":"1","key":"851_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2567.2011.03511.x","volume":"135","author":"T Deng","year":"2012","unstructured":"Deng T, Zhang Y, Chen Q, Yan K, Han D (2012) Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages. Immunology 135(1):40\u201350","journal-title":"Immunology"},{"issue":"7","key":"851_CR20","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.4049\/jimmunol.1302756","volume":"194","author":"T Fukazawa","year":"2015","unstructured":"Fukazawa T, Hiraiwa N, Umemura T, Mise-Omata S, Obata Y, Doi T (2015) Egress of mature murine regulatory T cells from the thymus requires RelA. Journal of immunology (Baltimore, Md : 1950) 194(7):3020\u20133028","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"key":"851_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.etap.2016.05.029","volume":"45","author":"Y Shen","year":"2016","unstructured":"Shen Y, Cui X, Rong Y, Zhang Z, Xiao L, Zhou T, Chen W (2016) Exogenous Gas6 attenuates silica-induced inflammation on differentiated THP-1 macrophages. Environ Toxicol Pharmacol 45:222\u2013226","journal-title":"Environ Toxicol Pharmacol"},{"issue":"5","key":"851_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0171-2985(97)80080-0","volume":"197","author":"V Kodelja","year":"1997","unstructured":"Kodelja V, Muller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S (1997) Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197(5):478\u2013493","journal-title":"Immunobiology"},{"issue":"6","key":"851_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00281-018-0698-5","volume":"40","author":"TA Werfel","year":"2018","unstructured":"Werfel TA, Cook RS (2018) Efferocytosis in the tumor microenvironment. Semin Immunopathol 40(6):545\u2013554","journal-title":"Semin Immunopathol"},{"issue":"1","key":"851_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","volume":"17","author":"N Jetten","year":"2014","unstructured":"Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM (2014) Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 17(1):109\u2013118","journal-title":"Angiogenesis"},{"key":"851_CR25","doi-asserted-by":"crossref","unstructured":"Vaught DB, Stanford JC, Cook RS: Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis. Cancer cell & microenvironment 2015, 2(1).","DOI":"10.1016\/B978-0-12-394447-4.30050-5"},{"issue":"7","key":"851_CR26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/JPER.18-0412","volume":"90","author":"B Afacan","year":"2019","unstructured":"Afacan B, Ozturk VO, Pasali C, Bozkurt E, Kose T, Emingil G (2019) Gingival crevicular fluid and salivary HIF-1alpha, VEGF, and TNF-alpha levels in periodontal health and disease. J Periodontol 90(7):788\u2013797","journal-title":"J Periodontol"},{"key":"851_CR27","doi-asserted-by":"crossref","unstructured":"Aral K, Milward MR, Kapila Y, Berdeli A, Cooper PR (2020) Inflammasomes and their regulation in periodontal disease: a review. J Periodontal Res","DOI":"10.1111\/jre.12733"},{"key":"851_CR28","doi-asserted-by":"publisher","first-page":"615486","DOI":"10.1155\/2015\/615486","volume":"2015","author":"SA Hienz","year":"2015","unstructured":"Hienz SA, Paliwal S, Ivanovski S (2015) Mechanisms of bone resorption in periodontitis. J Immunol Res 2015:615486","journal-title":"J Immunol Res"},{"issue":"Suppl 1","key":"851_CR29","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/JPER.17-0721","volume":"89","author":"PN Papapanou","year":"2018","unstructured":"Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F et al (2018) Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 89(Suppl 1):S173\u2013s182","journal-title":"J Periodontol"},{"issue":"Suppl 20","key":"851_CR30","first-page":"S28","volume":"45","author":"P Holmstrup","year":"2018","unstructured":"Holmstrup P, Plemons J, Meyle J (2018) Non-plaque-induced gingival diseases. J Clin Periodontol 45(Suppl 20):S28\u2013s43","journal-title":"J Clin Periodontol"},{"issue":"Suppl 20","key":"851_CR31","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1111\/jcpe.12941","volume":"45","author":"D Herrera","year":"2018","unstructured":"Herrera D, Retamal-Valdes B, Alonso B, Feres M (2018) Acute periodontal lesions (periodontal abscesses and necrotizing periodontal diseases) and endo-periodontal lesions. J Clin Periodontol 45(Suppl 20):S78\u2013s94","journal-title":"J Clin Periodontol"},{"issue":"1","key":"851_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research : the official journal of the American Society for Bone and Mineral Research 30(1):3\u201323","journal-title":"Journal of Bone and Mineral Research : the official journal of the American Society for Bone and Mineral Research"},{"key":"851_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schi\u00f8dt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177\u2013187","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"851_CR34","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s10096-014-2160-5","volume":"33","author":"J De Ceulaer","year":"2014","unstructured":"De Ceulaer J, Tacconelli E, Vandecasteele SJ (2014) Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 33(11):1873\u20131880","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"key":"851_CR35","doi-asserted-by":"crossref","unstructured":"Orriss IR, Key ML, Colston KW, Arnett TR: Inhibition of osteoblast function in vitro by aminobisphosphonates. Journal of cellular biochemistry 2009, 106(1):109-118 %@ 0730-2312.","DOI":"10.1002\/jcb.21983"},{"issue":"1","key":"851_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","volume":"14","author":"C Walter","year":"2010","unstructured":"Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14(1):35\u201341","journal-title":"Clin Oral Investig"},{"issue":"5","key":"851_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.joms.2013.11.005","volume":"72","author":"O Ristow","year":"2014","unstructured":"Ristow O, Gerngross C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, Hahnefeld L, Otto S, Pautke C (2014) Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 72(5):903\u2013910","journal-title":"Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons"},{"issue":"4","key":"851_CR38","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0022034515572021","volume":"94","author":"H Katsarelis","year":"2015","unstructured":"Katsarelis H, Shah NP, Dhariwal DK, Pazianas M (2015) Infection and medication-related osteonecrosis of the jaw. J Dent Res 94(4):534\u2013539","journal-title":"J Dent Res"},{"issue":"3","key":"851_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/annonc\/mdn788","volume":"20","author":"J Ayllon","year":"2009","unstructured":"Ayllon J, Launay-Vacher V, Medioni J, Cros C, Spano JP, Oudard S (2009) Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile? Annals of oncology : official journal of the European Society for Medical Oncology 20(3):600\u2013601","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"3","key":"851_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000201931","volume":"76","author":"C Christodoulou","year":"2009","unstructured":"Christodoulou C, Pervena A, Klouvas G, Galani E, Falagas ME, Tsakalos G, Visvikis A, Nikolakopoulou A, Acholos V, Karapanagiotidis G et al (2009) Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone. Oncology 76(3):209\u2013211","journal-title":"Oncology"},{"issue":"5","key":"851_CR41","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 66(5):839\u2013847","journal-title":"Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons"},{"issue":"5","key":"851_CR42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","volume":"68","author":"S Otto","year":"2010","unstructured":"Otto S, Hafner S, Mast G, Tischer T, Volkmer E, Schieker M, Sturzenbaum SR, von Tresckow E, Kolk A, Ehrenfeld M et al (2010) Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 68(5):1158\u20131161","journal-title":"Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons"},{"issue":"6812","key":"851_CR43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-$$. Nature 408(6812):600","journal-title":"Nature"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-020-00851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-020-00851-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-020-00851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T10:43:35Z","timestamp":1696157015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-020-00851-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s10006-020-00851-w","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"value":"1865-1550","type":"print"},{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}